FDA Class III · Drug · May 27, 2026
Busulfan Injection recall — Sagent Pharmaceuticals
Failed Impurities/Degradation Specifications
Official ID D-0539-2026 · Official record ↗
Recall found. Sagent Pharmaceuticals is named in FDA Class III recall D-0539-2026 covering Busulfan Injection. Hazard: Failed Impurities/Degradation Specifications Identifying details: Lot #: 656412, Exp. Date 08/31/2026; 659646, Exp. Date 03/31/2027.. Status: Ongoing.
Failed Impurities/Degradation Specifications
Official ID D-0539-2026 · Official record ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.